Results 21 - 26 of 26 : Previous 1 2 3
QLT announces first-quarter financial results.
QLT announces another dismal quarter of declining sales for its top compound.
Pharma continues to deliver growth through difficult times.
Tom Jacobs turns to the fun part of his portfolio: high risk.
Tom Jacobs finds another special biotech.
Tom Jacobs finds an underpriced drug maker.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK